Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Commentary on: Spanakis EK, Urrutia A, Galindo RJ, Vellanki P, Migdal AL, Davis G, Fayfman M, Idrees T, Pasquel FJ, Coronado WZ, Albury B, Moreno E, Singh LG, Marcano I, Lizama S, Gothong C, Munir K, Chesney C, Maguire R, Scott WH, Perez-Guzman MC, Cardona S, Peng L, Umpierrez GE. Continuous Glucose Monitoring-Guided Insulin Administration in Hospitalized Patients With Diabetes: A Randomized Clinical Trial. Diabetes Care. 2022 Oct 1;45(10):2369–2375. doi: 10.2337/dc22-0716. PMID: 35984478.
Implications for practice and research
Continuous glucose monitoring (CGM) devices are not inferior to point-of-care capillary glucose testing for inpatient glycaemic monitoring.
CGM devices could potentially reduce hypoglycaemic events in hospital, but require more research and training for acceptability in use.
Diabetes is a common metabolic disorder, present in more than 451 million people worldwide.1 The established practice for inpatient glycaemic monitoring when an individual whose diabetes is treated with basal-bolus insulin therapy is admitted to hospital is to use daily multiple bedside point-of-care (POC) capillary glucose testing. Guidelines recommend that POC testing …
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.